|
|
|
|
Suppliers for
Atosiban
|
Properties | | CAS |
90779-69-4 | | Formula |
C43H67N11O12S2 |
|
|
17 Registered suppliers
Molecular Formula: C45H71N11O14S2 Molecular Weight: 994.19 WGKGermany: 3
More details are to be found here
Molecular Formula: C45H71N11O14S2 Molecular Weight: 994.19 WGKGermany: 3
More details are to be found here
EINECS :806-815-5
Molecular formula :C43H67N11O12S2
EINECS :806-815-5
Molecular formula :C43H67N11O12S2
EINECS :806-815-5
Molecular formula :C43H67N11O12S2
EINECS :806-815-5
Molecular formula :C43H67N11O12S2
EINECS :806-815-5
Molecular formula :C43H67N11O12S2
EINECS :806-815-5
Molecular formula :C43H67N11O12S2
More details are to be found here
Description : Atosiban, a nonapeptide, desamino-oxytocin analogue, is a competitive inhibitor of the hormones oxytocin and vasopressinv. It inhibits the oxytocin-mediated release of inositol trisphosphate from the myometrial cell membrane. It is used as an intravenous medication as a labour repressant (tocolytic) to halt premature labor. It antagonises uterine contractions and induces uterine quiescence in human pre-term labour at the recommended dosage. It was developed by Ferring Pharmaceuticals in Sweden. It is licensed in proprietary and generic forms for the delay of imminent pre-term birth in pregnant adult women. - Molecular Weight :994.19
- Boiling Point :1469.0±65.0°C(Predicted)
- Purity :95%
Molecular Formula : C43H67N11O12S2 Canonical SMILES : CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCCC(=O)NC(C(=O)N1)CC2=CC=C(C=C2)OCC)C(=O)N3CCCC3C(=O)NC(CCCN)C(=O)NCC(=O)N)CC(=O)N)C(C)O
InChI :
InChI=1S/C43H67N11O12S2/c1-5-23(3)35-41(63)53-36(24(4)55)42(64)50-29(20-32(45)56)38(60)51-30(43(65)54-17-8-10-31(54)40(62)49-27(9-7-16-44)37(59)47-21-33(46)57)22-68-67-18-15-34(58)48-28(39(61)52-35)19-25-11-13-26(14-12-25)66-6-2/h11-14,23-24,27-31,35-36,5
InChIKey :
VWXRQYYUEIYXCZ-OBIMUBPZSA-N
Solubility :
Soluble in DMSO
Appearance :
Solid
Application :
Atosiban is used as an intravenous medication as a labour repressant (tocolytic) to halt premature labor.
Storage : Store at -20°C
Synonyms :
1-(3-Mercaptopropionic acid)-2-(3-(p-ethoxyphenyl)-D-alanine)-4-L-thre onine-8-L-ornithineoxytocin;[Mpr-D-Tyr(OEt)-Ile-Thr-Asn-Cys]-Pro-Orn-Gly-NH2;(2S)-N-[(1S)-4-Amino-1-(carbamoylmethylcarbamoyl)butyl]-1-[(4S,7S,13S,16R)-13-[(2S)-butan-2-yl]-7-(carbamoylmethyl)-16-[(4-ethoxyphenyl)methyl]-10-(1-hydroxyethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide;1-(3-Mercaptopropanoic acid)-2-(O-ethyl-D-tyrosine)-4-L-threonine-8-L-ornithineoxytocin;Tractocile;(2S)-N-[(2S)-5-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxopentan-2-yl]-1-[(4R,7S,10S,13S,16R)-7-(2-amino-2-oxoethyl)-13-[(2S)-butan-2-yl]-16-[(4-ethoxyphenyl)methyl]-10-[(1R)-1-hydroxyethyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide;RW22164; RWJ22164
More details are to be found here
Description : Atosiban, a nonapeptide, desamino-oxytocin analogue, is a competitive inhibitor of the hormones oxytocin and vasopressinv. It inhibits the oxytocin-mediated release of inositol trisphosphate from the myometrial cell membrane. It is used as an intravenous medication as a labour repressant (tocolytic) to halt premature labor. It antagonises uterine contractions and induces uterine quiescence in human pre-term labour at the recommended dosage. It was developed by Ferring Pharmaceuticals in Sweden. It is licensed in proprietary and generic forms for the delay of imminent pre-term birth in pregnant adult women. - Molecular Weight :994.19
- Boiling Point :1469.0±65.0°C(Predicted)
- Purity :95%
Molecular Formula : C43H67N11O12S2 Canonical SMILES : CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCCC(=O)NC(C(=O)N1)CC2=CC=C(C=C2)OCC)C(=O)N3CCCC3C(=O)NC(CCCN)C(=O)NCC(=O)N)CC(=O)N)C(C)O
InChI :
InChI=1S/C43H67N11O12S2/c1-5-23(3)35-41(63)53-36(24(4)55)42(64)50-29(20-32(45)56)38(60)51-30(43(65)54-17-8-10-31(54)40(62)49-27(9-7-16-44)37(59)47-21-33(46)57)22-68-67-18-15-34(58)48-28(39(61)52-35)19-25-11-13-26(14-12-25)66-6-2/h11-14,23-24,27-31,35-36,5
InChIKey :
VWXRQYYUEIYXCZ-OBIMUBPZSA-N
Solubility :
Soluble in DMSO
Appearance :
Solid
Application :
Atosiban is used as an intravenous medication as a labour repressant (tocolytic) to halt premature labor.
Storage : Store at -20°C
Synonyms :
1-(3-Mercaptopropionic acid)-2-(3-(p-ethoxyphenyl)-D-alanine)-4-L-thre onine-8-L-ornithineoxytocin;[Mpr-D-Tyr(OEt)-Ile-Thr-Asn-Cys]-Pro-Orn-Gly-NH2;(2S)-N-[(1S)-4-Amino-1-(carbamoylmethylcarbamoyl)butyl]-1-[(4S,7S,13S,16R)-13-[(2S)-butan-2-yl]-7-(carbamoylmethyl)-16-[(4-ethoxyphenyl)methyl]-10-(1-hydroxyethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide;1-(3-Mercaptopropanoic acid)-2-(O-ethyl-D-tyrosine)-4-L-threonine-8-L-ornithineoxytocin;Tractocile;(2S)-N-[(2S)-5-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxopentan-2-yl]-1-[(4R,7S,10S,13S,16R)-7-(2-amino-2-oxoethyl)-13-[(2S)-butan-2-yl]-16-[(4-ethoxyphenyl)methyl]-10-[(1R)-1-hydroxyethyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide;RW22164; RWJ22164
More details are to be found here
More details are to be found here
More details are to be found here
More details are to be found here
More details are to be found here
Detailed information on the suppliers of
Atosiban |
Properties:
... more properties and specification on Atosiban
|
|
Privileged suppliers
Last update 2024-05-31
|
details
details